Mo1200 NOVEL TONGUE IMAGING TECHNOLOGY HAS THE POTENTIAL TO DETECT COLONIC ADENOMAS: PRELIMINARY RESULTS FROM A TEST DATASET
Leggi →
Maggio 2024
Risultati per: Tumore prostata, test della saliva piu’ attendibile del PSA
Questo è quello che abbiamo trovato per te
Mo1176 DETECTION OF BIOMARKERS IN FECAL IMMUNOCHEMICAL TEST RESIDUAL BUFFER TO ENHANCE COLORECTAL CANCER SCREENING: A SYSTEMATIC SCOPING REVIEW
Leggi →
Maggio 2024
Mo1001 FACTORS ASSOCIATED WITH MAILED FECAL IMMUNOCHEMICAL TEST (FIT) COMPLETION IN AN INTEGRATED ACADEMIC-COMMUNITY HEALTHCARE SYSTEM.
Leggi →
Maggio 2024
Mo1008 CLINIC VARIATIONS IN COLONOSCOPY PROCESS MEASURES AFTER A POSITIVE STOOL TEST: A RETROSPECTIVE ANALYSIS WITHIN AN INTEGRATED SAFETY-NET HEALTH SYSTEM
Leggi →
Maggio 2024
Su1160 DEVELOPMENT OF A SECOND-GENERATION MULTI-TARGET STOOL RNA TEST (COLOSENSE 2.0) FOR COLORECTAL CANCER SCREENING
Leggi →
Maggio 2024
Mo1022 ELECTRONIC CODING FOR ABNORMAL FECAL IMMUNOCHEMICAL TEST IS ASSOCIATED WITH INCREASED COLONOSCOPY COMPLETION
Leggi →
Maggio 2024
Mo1026 INTEGRATION OF A BLOOD-BASED COLORECTAL CANCER SCREENING TEST INTO ROUTINE RADIOLOGY IMAGING VISITS IMPROVES OVERALL SCREENING RATES
Leggi →
Maggio 2024
Mo1041 STANDARDIZED ORDER SETS FOR RISK-BASED COLORECTAL CANCER SCREENING INCREASE UTILIZATION OF STOOL-BASED TEST
Leggi →
Maggio 2024
Mo1036 PROACTIVE OUTREACH WITH MAILED FECAL IMMUNOCHEMICAL TEST (FIT) AND NAVIGATION ENHANCES COLORECTAL CANCER SCREENING AMONG BLACKS AT AN URBAN FEDERALLY QUALIFIED HEALTH CENTER
Leggi →
Maggio 2024
908 CHARACTERISTICS OF A COST-EFFECTIVE BLOOD TEST FOR COLORECTAL CANCER SCREENING
Leggi →
Maggio 2024
Sa1130 MULTICHANNEL RECRUITMENT ENABLED BROAD GEOGRAPHICAL REACH IN AN AVERAGE RISK POPULATION SCREENING STUDY FOR A BLOOD BASED TEST FOR THE EARLY DETECTION OF COLORECTAL CANCER
Leggi →
Maggio 2024
Sa1131 DIAGNOSTIC PERFORMANCE OF QUANTITATIVE FECAL IMMUNOCHEMICAL TEST FOR COLORECTAL CANCER; THE EFFECTS OF ONE-DAY VERSUS TWO DAY TEST
Leggi →
Maggio 2024
Sa1124 POSITIVITY OF FECAL IMMUNOCHEMICAL TEST IN THE LARGEST SAMPLE OF AVERAGE RISK OF COLORECTAL CANCER MEXICANS.
Leggi →
Maggio 2024
410 TEMPORAL CHANGE OF T1N1 STAGE III COLORECTAL CANCER IN THE CONTEXT OF FECAL IMMUNOCHEMICAL TEST-BASED COLORECTAL CANCER SCREENING PROGRAM IMPLEMENTATION AND ITS POTENTIAL IMPACT ON SCREENING EFFECTIVENESS
Leggi →
Maggio 2024
Sa1247 CLINICAL MONITORING OF EOSINOPHILIC ESOPHAGITIS USING THE ESOPHAGEAL STRING TEST
Leggi →
Maggio 2024
1090 RISK PREDICTION FOR COLORECTAL CANCER USING QUANTITATIVE FECAL IMMUNOCHEMICAL TEST RESULTS — A STATISTICAL SOLUTION TO THE COLONOSCOPY CAPACITY ISSUE
Leggi →
Maggio 2024
